461 |
3EJY |
CD_A |
3EJY Fab |
H(+)/Cl(-) exchange transporter clcA |
Escherichia coli, Mus musculus |
XRD |
3.2 | 10.1085/jgp.200810112 |
462 |
3EJY |
EF_B |
3EJY Fab |
H(+)/Cl(-) exchange transporter clcA |
Escherichia coli, Mus musculus |
XRD |
3.2 | 10.1085/jgp.200810112 |
463 |
3EJZ |
CD_A |
3EJZ Fab |
H(+)/Cl(-) exchange transporter clcA |
Escherichia coli, Mus musculus |
XRD |
2.9 | 10.1085/jgp.200810112 |
464 |
3EJZ |
EF_B |
3EJZ Fab |
H(+)/Cl(-) exchange transporter clcA |
Escherichia coli, Mus musculus |
XRD |
2.9 | 10.1085/jgp.200810112 |
465 |
3EO1 |
BA_C |
GC-1008 Fab |
Transforming growth factor beta-3 |
Mus musculus, Homo sapiens |
XRD |
3.1 | 10.1073/pnas.0807200106 |
466 |
3EO1 |
ED_F |
GC-1008 Fab |
Transforming growth factor beta-3 |
Mus musculus, Homo sapiens |
XRD |
3.1 | 10.1073/pnas.0807200106 |
467 |
3EO1 |
KJ_L |
GC-1008 Fab |
Transforming growth factor beta-3 |
Mus musculus, Homo sapiens |
XRD |
3.1 | 10.1073/pnas.0807200106 |
468 |
3EO1 |
HG_I |
GC-1008 Fab |
Transforming growth factor beta-3 |
Mus musculus, Homo sapiens |
XRD |
3.1 | 10.1073/pnas.0807200106 |
469 |
3EOA |
HL_I |
Efalizumab Fab |
Integrin alpha-L |
Homo sapiens |
XRD |
2.8 | 10.1073/pnas.0810844106 |
470 |
3EOA |
BA_J |
Efalizumab Fab |
Integrin alpha-L |
Homo sapiens |
XRD |
2.8 | 10.1073/pnas.0810844106 |
471 |
3EOB |
HL_I |
Efalizumab Fab |
Integrin alpha-L |
Homo sapiens |
XRD |
3.6 | 10.1073/pnas.0810844106 |
472 |
3EOB |
BA_J |
Efalizumab Fab |
Integrin alpha-L |
Homo sapiens |
XRD |
3.6 | 10.1073/pnas.0810844106 |
473 |
3ETB |
F_J |
M18 scFv |
anthrax protective antigen domain 4 |
Mus musculus, Bacillus anthracis |
XRD |
3.8 | 10.1016/j.jmb.2009.02.003 |
474 |
3ETB |
G_K |
M18 scFv |
anthrax protective antigen domain 4 |
Mus musculus, Bacillus anthracis |
XRD |
3.8 | 10.1016/j.jmb.2009.02.003 |
475 |
3ETB |
H_L |
M18 scFv |
anthrax protective antigen domain 4 |
Mus musculus, Bacillus anthracis |
XRD |
3.8 | 10.1016/j.jmb.2009.02.003 |
476 |
3ETB |
I_M |
M18 scFv |
anthrax protective antigen domain 4 |
Mus musculus, Bacillus anthracis |
XRD |
3.8 | 10.1016/j.jmb.2009.02.003 |
477 |
3EZJ |
B_A |
NBGSPD_7 Nanobody |
General secretion pathway protein GspD |
Escherichia coli ETEC H10407, Lama glama |
XRD |
2.8 | 10.1016/j.str.2008.11.011 |
478 |
3EZJ |
D_C |
NBGSPD_7 Nanobody |
General secretion pathway protein GspD |
Escherichia coli ETEC H10407, Lama glama |
XRD |
2.8 | 10.1016/j.str.2008.11.011 |
479 |
3EZJ |
F_E |
NBGSPD_7 Nanobody |
General secretion pathway protein GspD |
Escherichia coli ETEC H10407, Lama glama |
XRD |
2.8 | 10.1016/j.str.2008.11.011 |
480 |
3EZJ |
H_G |
NBGSPD_7 Nanobody |
General secretion pathway protein GspD |
Escherichia coli ETEC H10407, Lama glama |
XRD |
2.8 | 10.1016/j.str.2008.11.011 |